JP2006524565A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524565A5
JP2006524565A5 JP2006505309A JP2006505309A JP2006524565A5 JP 2006524565 A5 JP2006524565 A5 JP 2006524565A5 JP 2006505309 A JP2006505309 A JP 2006505309A JP 2006505309 A JP2006505309 A JP 2006505309A JP 2006524565 A5 JP2006524565 A5 JP 2006524565A5
Authority
JP
Japan
Prior art keywords
particles
organic
compound
inorganic
liquid medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006505309A
Other languages
English (en)
Japanese (ja)
Other versions
JP5207432B2 (ja
JP2006524565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/004506 external-priority patent/WO2004096405A1/en
Publication of JP2006524565A publication Critical patent/JP2006524565A/ja
Publication of JP2006524565A5 publication Critical patent/JP2006524565A5/ja
Application granted granted Critical
Publication of JP5207432B2 publication Critical patent/JP5207432B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006505309A 2003-04-29 2004-04-28 アンチ溶媒凝固プロセス Expired - Fee Related JP5207432B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46676103P 2003-04-29 2003-04-29
US60/466,761 2003-04-29
PCT/EP2004/004506 WO2004096405A1 (en) 2003-04-29 2004-04-28 Antisolvent solidification process

Publications (3)

Publication Number Publication Date
JP2006524565A JP2006524565A (ja) 2006-11-02
JP2006524565A5 true JP2006524565A5 (cg-RX-API-DMAC7.html) 2007-07-05
JP5207432B2 JP5207432B2 (ja) 2013-06-12

Family

ID=33418418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505309A Expired - Fee Related JP5207432B2 (ja) 2003-04-29 2004-04-28 アンチ溶媒凝固プロセス

Country Status (22)

Country Link
US (4) US20060182808A1 (cg-RX-API-DMAC7.html)
EP (1) EP1620193B1 (cg-RX-API-DMAC7.html)
JP (1) JP5207432B2 (cg-RX-API-DMAC7.html)
KR (1) KR20060006949A (cg-RX-API-DMAC7.html)
CN (1) CN100434133C (cg-RX-API-DMAC7.html)
AR (1) AR044140A1 (cg-RX-API-DMAC7.html)
AT (1) ATE406946T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004234057A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0409860A (cg-RX-API-DMAC7.html)
CA (1) CA2523883C (cg-RX-API-DMAC7.html)
CL (1) CL2004000912A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004016311D1 (cg-RX-API-DMAC7.html)
ES (1) ES2312996T3 (cg-RX-API-DMAC7.html)
IL (1) IL171613A (cg-RX-API-DMAC7.html)
MX (1) MXPA05011626A (cg-RX-API-DMAC7.html)
MY (1) MY141189A (cg-RX-API-DMAC7.html)
NO (1) NO20055607D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ543772A (cg-RX-API-DMAC7.html)
RU (1) RU2339364C2 (cg-RX-API-DMAC7.html)
TW (1) TW200500095A (cg-RX-API-DMAC7.html)
WO (1) WO2004096405A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200509597B (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101262846A (zh) * 2005-07-15 2008-09-10 Map药物公司 在离散的吸入粒子中结合的多种活性药物成分及其制剂
AU2006272438B2 (en) * 2005-07-15 2011-08-04 Map Pharmaceuticals, Inc. Method of particle formation
US7942990B2 (en) 2006-12-18 2011-05-17 Daicel Chemical Industries, Ltd. Hybrid inflator
MX2009007834A (es) * 2007-01-22 2009-09-10 Cargill Inc Metodo para producir composiciones de rebaudiosido a purificado usando cristalizacion en solvente/ antisolvente.
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
FI120527B (fi) * 2007-06-18 2009-11-30 Crisolteq Oy Talteenottomenetelmä
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
US20100291221A1 (en) * 2009-05-15 2010-11-18 Robert Owen Cook Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
TWI466709B (zh) * 2011-07-20 2015-01-01 Nat Univ Chung Hsing From the original berry Wolfberry a liquid - liquid freezing method for separation of high purity theaflavins palmitate Maize
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9452930B2 (en) * 2013-11-04 2016-09-27 New Jersey Institute Of Technology System and method for continuous polymer coating of particles
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
PT108368B (pt) 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN106853295A (zh) * 2015-12-09 2017-06-16 北大方正集团有限公司 一种基于膜分散的结晶方法
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US10881123B2 (en) 2017-10-27 2021-01-05 Frito-Lay North America, Inc. Crystal morphology for sodium reduction
WO2019239550A1 (ja) * 2018-06-14 2019-12-19 日揮株式会社 晶析装置及び晶析方法
CN119679728A (zh) * 2018-12-28 2025-03-25 四川科伦药物研究院有限公司 制备黄体酮颗粒物的方法、所得黄体酮颗粒物及其注射剂
CN111234431A (zh) * 2020-03-31 2020-06-05 宁夏颐星新材料科技有限公司 一种消泡型聚乙烯醇粉末的生产工艺
GB202004824D0 (en) 2020-04-01 2020-05-13 Naturbeads Ltd Biopolymer particle preparation
GB202011836D0 (en) 2020-07-30 2020-09-16 Micropore Tech Limited Crystallisation methods
CN115777906A (zh) * 2021-09-10 2023-03-14 吉林大学 氯化钠纳微米粒子及其制备方法和应用
EP4637720A1 (en) 2022-12-22 2025-10-29 Nanomi B.V. Process for preparing stable nanoparticle and composition thereof
CN117942426B (zh) * 2024-03-22 2024-05-31 四川大学 一种具有取向孔道结构的多级多孔材料及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716453B1 (fr) * 1994-02-22 1996-03-29 Rhone Poulenc Agrochimie Procédé de sulfinylation de composés hétérocycliques.
US4089843A (en) * 1976-09-20 1978-05-16 The Upjohn Company Precipitating polymers in powder form
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4783484A (en) * 1984-10-05 1988-11-08 University Of Rochester Particulate composition and use thereof as antimicrobial agent
JPH0672528B2 (ja) * 1985-07-16 1994-09-14 三信工業株式会社 船舶のエンジン
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
US5269926A (en) * 1991-09-09 1993-12-14 Wisconsin Alumni Research Foundation Supported microporous ceramic membranes
FR2658498B1 (fr) * 1990-02-19 1992-05-15 Atochem Particules de chlorure de magnesium a structure tronc conique, composante catalytique supportee sur ces particules, polyolefines obtenues a partir de cette composante catalytique, procedes de fabrication de ces produits.
JP2555475B2 (ja) * 1990-10-16 1996-11-20 工業技術院長 無機質微小球体の製造方法
JP2816597B2 (ja) * 1990-11-28 1998-10-27 富士写真フイルム株式会社 溶液の均一混合装置および弾性体多孔膜
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
WO1993000156A1 (fr) * 1991-06-29 1993-01-07 Miyazaki-Ken Emulsions monodispersees simples et doubles et procede de production
SG43179A1 (en) * 1991-12-18 1997-10-17 Warner Lambert Co A process for the prepatation of a solid dispersion
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
NZ276277A (en) * 1993-11-08 1998-04-27 Gillette Co Antiperspirant compound, in aerogel form, being an aluminium salt, a zirconium salt or an aluminium-zirconium salt
JP3492787B2 (ja) * 1994-04-15 2004-02-03 信越化学工業株式会社 固形製剤のコーティング用水性エマルジョンの濃縮方法
US6387399B1 (en) * 1994-12-02 2002-05-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microencapsulated bioactive agents and method of making
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5876480A (en) * 1996-02-20 1999-03-02 The United States Of America As Represented By The Secretary Of The Navy Synthesis of unagglomerated metal nano-particles at membrane interfaces
GB9610955D0 (en) * 1996-05-24 1996-07-31 Hercules Inc Sizing composition
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US5879715A (en) * 1997-09-02 1999-03-09 Ceramem Corporation Process and system for production of inorganic nanoparticles
ES2272066T3 (es) * 1998-04-09 2007-04-16 F. Hoffmann-La Roche Ag Proceso para la manufactura de particulas con tamaño de (sub)micras por disolucion de gas comprimido y surfactantes.
SE9801287D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Incorporation of active substances in carrier matrixes
US6113795A (en) * 1998-11-17 2000-09-05 The University Of Kansas Process and apparatus for size selective separation of micro- and nano-particles
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
IN191236B (cg-RX-API-DMAC7.html) * 1999-05-25 2003-10-11 Ranbaxy Lab Ltd
US6780507B2 (en) * 2000-02-09 2004-08-24 Analytical Research Systems, Inc. Hydrocapsules and method of preparation thereof
US6623761B2 (en) * 2000-12-22 2003-09-23 Hassan Emadeldin M. Method of making nanoparticles of substantially water insoluble materials
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
WO2003032951A1 (en) * 2001-08-29 2003-04-24 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
CA2462338C (en) * 2001-10-10 2011-04-19 Boehringer Ingelheim Pharmaceuticals, Inc. Powder processing with pressurized gaseous fluids
US6890592B2 (en) * 2002-03-13 2005-05-10 Appleton Papers Inc. Uniform microcapsules
US6966990B2 (en) * 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing

Similar Documents

Publication Publication Date Title
CA2523883A1 (en) Antisolvent solidification process
DE69105106T2 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
York Strategies for particle design using supercritical fluid technologies
EP2822539B1 (en) Nanocrystalline solid dispersion compositions
JP2009502487A5 (cg-RX-API-DMAC7.html)
Kalpana et al. Solid Dispersion: Approaches, Technology involved, Unmet need & Challenges.
Paradkar et al. Preparation and evaluation of ibuprofen beads by melt solidification technique
UA127892C2 (uk) Спосіб одержання частинок ізоксазоліну великого розміру
CN109071461A (zh) 制备5-氨基-2,3-二氢噻嗪-1,4-二酮结晶体的方法
JPH09503522A (ja) S(+)−イブプロフェン粒子の製造方法
Newa et al. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000
JP3578993B2 (ja) コア/シェル構造を有する凝集体の製造方法
CN101874784B (zh) 析出结晶药物缓控释微球粒及其制备方法
CN1149824A (zh) 珠的制法以及含有熔点不确定活性成份的珠状物
US20170304207A1 (en) Manufacture of a pharmaceutical product
CN105943498A (zh) 一种不同尺度plga微纳载体的可控乳化制备方法
TH68562A (th) กรรมวิธีการทำให้เป็นของแข็งแบบต่อต้านตัวทำละลาย
CN111454255A (zh) 一种小粒度阿齐沙坦的制备方法
Patil et al. SOLID DISPERSION: AN EVOLUTIONARY PLAN FOR SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUGS.
JP3172695B2 (ja) 球形晶析法による直打用アスコルビン酸原末造粒物、その製造法およびそれを用いた錠剤
Muthukumar Chapter-6 Solid Dispersion
Yadav et al. solubility enhancement and bioavailability improvement strategies
CN112999224A (zh) 一种布洛芬载来那度胺复合颗粒及其制备方法
JP2000080072A (ja) L―アルギニンの製造法
Dizaj et al. Spherical Crystallization of Drugs